Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sustained antidepressant effect of PEA replacement

H Sabelli1, P Fink, J Fawcett

  • 1Rush University and the Center for Creative Development, Chicago, Illinois, USA.

The Journal of Neuropsychiatry and Clinical Neurosciences
|January 1, 1996
PubMed
Summary

Phenylethylamine (PEA) shows sustained antidepressant effects in most patients, offering relief for depression, even in those unresponsive to standard treatments. This neuroamine improves mood rapidly without causing tolerance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Muscle abnormalities in Long COVID.

Nature communications·2025
Same author

Reply: Muscle abnormalities in Long COVID.

Nature communications·2025
Same author

Prevalence of and risk factors for self-reported menstrual changes following COVID-19 vaccination: a Danish cohort study.

Human reproduction (Oxford, England)·2023
Same author

Immediate adverse reactions following COVID-19 vaccination among 16-65-year-old Danish citizens.

Vaccine·2023
Same author

Retrospective spatial analysis of cases of COVID-19 in a single military accommodation block corridor, RMAS, January-March 21.

BMJ military health·2022
Same author

Chronic effects of the strobilurin fungicide azoxystrobin in the leaf shredder Gammarus fossarum (Crustacea; Amphipoda) via two effect pathways.

Ecotoxicology and environmental safety·2021

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Phenylethylamine (PEA) is an endogenous neuroamine with stimulant properties.
  • A PEA deficit is hypothesized to contribute to certain forms of depression.
  • PEA has demonstrated antidepressant effects in 60% of patients.

Observation:

  • Fourteen patients with major depressive episodes were treated with PEA (10-60 mg/day) and selegiline (10 mg/day).
  • Patients were re-evaluated after 20-50 weeks of continuous treatment.
  • The study observed the long-term efficacy and side effects of PEA treatment.

Findings:

  • Antidepressant response was maintained in 12 out of 14 patients.
  • Effective PEA dosage remained consistent over the treatment period.

Related Experiment Videos

  • No significant side effects were reported during the study.
  • PEA provided sustained depression relief, including in patients resistant to other treatments.
  • PEA demonstrated rapid mood improvement comparable to amphetamine without inducing tolerance.

    • Implications:

    • PEA may be a viable long-term treatment for major depressive episodes.
    • PEA offers a potential therapeutic option for treatment-resistant depression.
    • Further research into PEA's neurobiological mechanisms in depression is warranted.